SCHEMBL6299244

SCHEMBL6299244

ClCCc1cc(Cl)ccc1Sc1ccc(Cl)cc1CCCl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.44
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 4/20 0.42
HIF1A Q16665 3/20 0.42
HPGD P15428 3/20 0.42
HTT P42858 3/20 0.42
CYP2C19 P33261 3/20 0.42
MEN1 O00255 2/20 0.42
HSP90AA1 P07900 2/20 0.42
ALOX15 P16050 2/20 0.42
KMT2A Q03164 2/20 0.42
PLA2G1B P04054 2/20 0.42
CYP2D6 P10635 2/20 0.42
ATG4B Q9Y4P1 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SLC6A2 P23975 3/20 0.41
SLC6A3 Q01959 3/20 0.41
ITGB2 P05107 3/20 0.40
ICAM1 P05362 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3196242 0.83 SLC6A4 (0.46) SLC6A4CYP3A4CYP2C9HIF1AHPGD
SCHEMBL2154366 0.82 ITGB2 (0.47) SLC6A4CYP3A4CYP2C9HIF1AHPGD
SCHEMBL6299441 0.78 SLC6A4 (0.44) SLC6A4HPGDMEN1ALOX15KMT2A
SCHEMBL4440726 0.77 SLC6A4 (0.66) SLC6A4CYP3A4CYP2C9HIF1AHPGD
SCHEMBL9183333 0.76 TP53 (0.46) CYP3A4CYP2C9HIF1AHPGDHTT
SCHEMBL10534359 0.74 IDO1 (0.40) CYP3A4CYP2C9HIF1AHPGDHTT
SCHEMBL10534385 0.74 IDO1 (0.40) CYP3A4CYP2C9HIF1AHPGDHTT
SCHEMBL9746559 0.73 MEN1 (0.46) SLC6A4CYP3A4CYP2C9HIF1AHPGD
SCHEMBL4967338 0.72 NOS3 (0.41) CYP3A4CYP2C9HIF1AHPGDHTT
SCHEMBL6299246 0.72 IDO1 (0.39) CYP3A4CYP2C9HIF1AHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6942966-B1 libraries formed by permutations; combinatorial chemistry; drug screening ISIS PHARMACEUTICALS, INC. (US) 2005-09-13 US disclosed
US-6559303-B1 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical ISIS PHARMACEUTICALS, INC. 2003-05-06 US disclosed
US-6329523-B1 FOR ANTIBACTERIAL PHARMACEUTICAL USE, USEFUL FOR IDENTIFYING METAL CHELATING SPECIES FOR ?HEAVY METAL? THERAPY; IMAGING AGENTS ISIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
US-6207826-B1 Macrocyclic compounds having nitrogen-containing linkages ISIS PHARMACEUTICALS, INC. 2001-03-27 US disclosed
US-6197965-B1 POLYARYLALKYLAMINO-SUBSTITUED PYRIDINE DERIVATIVES; DRUGS, MEDICINE, DIAGNOSTICS ISIS PHARMACEUTICALS, INC. 2001-03-06 US disclosed
EP-0817787-A4 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2000-09-13 EP disclosed
WO-1998010286-A1 METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS ISIS PHARMACEUTICALS, INC. (US) 1998-03-12 WO disclosed
WO-1998005961-A1 COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS ISIS PHARMACEUTICALS, INC. (US) 1998-02-12 WO disclosed
EP-0817787-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1998-01-14 EP disclosed
WO-1996030377-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1996-10-03 WO disclosed
EP-0529395-A2 Benzamide multidrug resistance reversing agents Bristol-Myers Squibb Company (US) 1993-03-03 EP disclosed
US-4724235-A N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia A. H. ROBINS COMPANY, INCORPORATED (US) 1988-02-09 US disclosed
US-4597902-A TREATMENT OF CARDIAC ARRHYTHMIAS A. H. ROBINS COMPANY, INCORPORATED (US) 1986-07-01 US disclosed
EP-0066415-B1 N-(ARYLTHIOALKYL)-N'-(AMINOALKYL)UREAS A.H. ROBINS COMPANY, INCORPORATED (US) 1985-10-02 EP disclosed
EP-0066415-A2 N-(arylthioalkyl)-N'-(aminoalkyl)ureas A.H. ROBINS COMPANY, INCORPORATED (US) 1982-12-08 EP disclosed